Adalimumab rapidly induces clinical remission and response in patients with moderate to severe Crohn's disease who had secondary failure to infliximab therapy: Results of the GAIN study

被引：9
|
作者：
Sandborn, William J.
Rutgeerts, P.
Enns, R. A.
Hanauer, S. B.
Colombel, J. F.
Panaccione, R.
Kent, J. D.
Pollack, P. F.
机构：
[1] Mayo Clin Rochester, Rochester, MN USA
[2] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium
[3] St Pauls Hosp, Pacif Gastroenterol Assoc, Vancouver, BC V6Z 1Y6, Canada
[4] Univ Chicago, Chicago, IL 60637 USA
[5] CHU Lille, F-59037 Lille, France
[6] Univ Calgary, Inflammatory Bowel Dis Clin, Calgary, AB, Canada
[7] Immunol Dev, Abbott Pk, IL USA
[8] Immunol Dev, Parsippany, NJ USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2006年 / 101卷 / 09期
关键词：
D O I：
10.14309/00000434-200609001-01147
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1147
引用
收藏
页码：S448 / S448
页数：1
相关论文
共 50 条
  • [31] Adalimumab maintains clinical remission and response, induces and maintains healing of draining fistulas in patients with active crohn's disease
    Kamm, M. A.
    Colombel, J.
    Sandborn, W. J.
    Rutgeerts, P.
    Enns, R. A.
    Hanauer, S. B.
    Panaccione, R.
    Schreiber, S.
    Lomax, K. G.
    Pollack, P. F.
    [J]. GUT, 2007, 56 : A21 - A21
  • [32] An open label study of adalimumab in Crohn's disease patients with a loss of response to infliximab
    Anwar, Malik
    O'Sullivan, Maria
    Ryan, Barbara
    Breslin, Niall
    O'Connor, Humphrey
    O'Morain, Colm
    [J]. GASTROENTEROLOGY, 2006, 130 (04) : A662 - A662
  • [33] Natalizumab induces sustained response and remission in Crohn's patients after previous infliximab failure: Results from the encore trial
    Present, Daniel
    Feagan, Brian G.
    Fedorak, Richard N.
    Lashner, Bret
    Panaccione, Remo
    Rutgeerts, Paul
    Sandborn, William J.
    Spehlmann, Martina E.
    Tulassay, Zsolt
    Volfova, Mirostava
    Wolf, Douglas C.
    Targan, Stephan R.
    [J]. GASTROENTEROLOGY, 2007, 132 (04) : A507 - A507
  • [34] Adalimumab Induces and Maintains Mucosal Healing in Patients with Moderate to Severe Ileocolonic Crohn's Disease - First Results of the Extend Trial
    Rutgeerts, Paul
    D'Haens, Geert R.
    Van Assche, Gert A.
    Sandborn, William J.
    Wolf, Douglas C.
    Colombel, Jean-Frederic
    Reinisch, Walter
    Geboes, Karel
    Khan, Mahmudul
    Lazar, Andreas
    Camez, Anne
    Pollack, Paul F.
    [J]. GASTROENTEROLOGY, 2009, 136 (05) : A116 - A116
  • [35] Long-Term Outcome of Patients With Crohn's Disease Who Discontinued Infliximab Therapy Upon Clinical Remission
    Papamichael, Konstantinos
    Casteele, Niels Vande
    Gils, Ann
    Tops, Sophie
    Hauenstein, Scott
    Singh, Sharat
    Princen, Fred
    Van Assche, Gert
    Rutgeerts, Paul
    Vermeire, Severine
    Ferrante, Marc
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (06) : 1103 - 1110
  • [36] Adalimumab Therapy maintains steroid-free remission and Fistula Closure in patients with moderate to severe Crohn's Disease Results of an Open-Label Study in Canada (ACCESS)
    Panaccione, R.
    Loftus, E., Jr.
    Binion, D.
    McHugh, K.
    Chen, N.
    Chao, J.
    Mulani, P.
    [J]. INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : S43 - S43
  • [37] C-Reactive Protein Levels in Moderate to Severe Crohn's Disease Patients Decreased Rapidly and Significantly During Adalimumab Therapy
    Ghosh, Subrata
    Wu, Eric
    Bensimon, Arielle
    Mulani, Parvez
    Yang, Mei
    Chao, Jingdong
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S450 - S450
  • [38] Treatment of Secondary Infliximab Failure in Crohn's Disease Based on Serum Levels of Infliximab and Antibodies Against Infliximab: The Danish Study of Optimizing Infliximab Therapy in Crohn's Disease (Do It Crohn) Randomized Clinical Trial
    Steenholdt, Casper
    Brynskov, Jorn
    Thomsen, Ole
    Munck, Lars K.
    Fallingborg, Jan
    Christensen, Lisbet A.
    Pedersen, Gitte
    Kjeldsen, Jens
    Jacobsen, Bent A.
    Oxholm, Anne Sophie
    Kjellberg, Jakob
    Bendtzen, Klaus
    Ainsworth, Mark A.
    [J]. GASTROENTEROLOGY, 2013, 144 (05) : S22 - S22
  • [39] Short-term adalimumab therapy improves quality of life in patients who had failed infliximab therapy: Results from the gain trial
    Loftus, Edward V.
    Colombel, Jean-frederic
    Rutgeerts, Paul J.
    D'haens, Geen R.
    Enns, Robert A.
    Mulani, Parvez M.
    Pollack, Paul F.
    [J]. GASTROENTEROLOGY, 2007, 132 (04) : A508 - A508
  • [40] Adalimumab, a human anti-TNF-α monoclonal antibody, induces clinical remission and response in patients with moderate to severely active Crohn's Disease irrespective of smoking status
    Sandborn, W
    Hanauer, S
    Panaccione, R
    Rutgeerts, P
    Pollack, P
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S259 - S260
12345